• Info
  • Social Media
  • Title

    Historic CHIPSA Hospital Now Offering Ibogaine Detox

  • Summary

    The world famous CHIPSA Hospital is now offering Ibogaine treatment for patients suffering from opiate addiction. This holistic treatment allows patients to detox with little to no withdrawals.

  • Press Release Video
    Loading the player...
  • Details
    (prREACH)

    The world famous CHIPSA Gerson hospital is now offering Ibogaine Treatment for opiate addiction.CHIPSA established the first multidisciplinary integrative medical protocols in North America, involving the integration of Immunonutrition Therapy along with advance immunity enhancing protocols currently recommended by the National Institute of Health (NIH).

    CHIPSA built its reputation treating cancer and degenerative disease with immunological enhancing treatments. Thousands of patients over the 36 year history of the CHIPSA Hospital have sought treatment for cancer, advanced rheumatoid arthritis, diabetes, hepatitis C, and now addiction.

    The new Ibogaine Institute at the CHIPSA Hospital shows promise. The establishment of the Institute signifies an opportunity for patients seeking alternative opiate addiction treatment with Ibogaine to be treated in a hospital environment.  Currently, ibogaine is administered by small family owned practitioners, often with little oversight or access to the resources of a hospital.  The Institute at CHIPSA is a major turning point in opaite addiction.

    Ibogaine has been used for thousands of years in Gabon Africa, notably by the Bwiti tribe as a sacrament. It was discovered by accident by the man who is now considered the Godfather of the Ibogaine movement Howard Lotsoff. Lotsoff worked for years to achieve approval in the Unites States and found a partner in Dr. Deborah Mash. Despite amazing results in over a decades-long study, beginning in 1996 in St. Kitts, Mash was unable to gain any traction in America despite being celebrated virtually all over the globe.

    CASE STUDY Over the next three months, CHIPSA is seeking respondents in an inaugural case study to measure the short term efficacy of ibogaine.  Standard ibogaine detox in North America averages $6740 per treatment.  The CHIPSA Hospital is subsidizing the cost of treatment, up to $3000 for qualified applicants.  Not only will this research help practitioners better understand the implications on patients as they return home free from addiction, it is in line with the CHIPSA Hospital mission of providing affordable healthcare for patients who may not have any other options.

    For more information or to apply for the case study, call 1-855-642-4772 or email [email protected]

  • Links
  • Quotes
    "Ibogaine is a strong addition to the 36 year history of CHIPSA Hospital. Ibogaine's ability to interrupt opiate addiction is second to none and its ability to stop nearly 100% of withdrawals is unprecedented in modern addiction medicine"
    - CHIPSA Medical Director
  • Images
  • Contact

    Allen Perry

    855-624-4772

    http://www.CHIPSAHospital.org

  • Follow Us
  • Visit Site